Stelzer P, Bilkei G, Clavadetscher E, Biro O, Takacs T, Kotai I, Bilkei H
Konsulentenbüro für Krisenmanagement in der Schweinezucht, Dübendorf, Schweiz.
Berl Munch Tierarztl Wochenschr. 1997 Sep;110(9):320-3.
Periparturient biotechniques with prednisolon are widely used in Europe for the prevention of perinatal losses in intensive pig production. However, the routinely applied 100 mg prednisolon on the 113th day of pregnancy to the sow are not without controversy. In four intensive pig production units altogether 2143 sows treated thus were subjected to the evaluation of the following parameters: A: the presence or absence of vulvar discharge at the 110th day of pregnancy B: postparturient disease of the sow C: early postnatal piglet losses The results showed that the sows having prepartal vulvar discharge developed after prednisolon application significantly (p < 0.001) higher incidence of postparturient disease (20.5% versus 9.3%) when compared to the sows having no prepartal vulvar discharge. The early postnatal losses were significantly higher (p < 0.05) in sows having prepartal vulvar discharge and consecutive postparturient disease when compared to the healthy sows. It is the opinion of the authors that prepartal biotechnique with prednisolon (in order to reduce perinatal losses) in sows showing the signs of prepartal vulvar discharge is contraindicated.
在欧洲，围产期使用泼尼松龙的生物技术被广泛应用于集约化养猪生产中，以预防围产期损失。然而，在母猪怀孕第113天常规使用100毫克泼尼松龙并非毫无争议。在四个集约化养猪生产单位中，共有2143头接受该处理的母猪接受了以下参数的评估：A：怀孕第110天是否有外阴分泌物；B：母猪产后疾病；C：产后早期仔猪损失。结果表明，与产前没有外阴分泌物的母猪相比，产前有外阴分泌物的母猪在使用泼尼松龙后产后疾病的发生率显著更高（p < 0.001）（20.5%对9.3%）。与健康母猪相比，产前有外阴分泌物且随后患有产后疾病的母猪产后早期损失显著更高（p < 0.05）。作者认为，对于有产前外阴分泌物迹象的母猪，使用泼尼松龙进行产前生物技术处理（以减少围产期损失）是禁忌的。
